Joseph M. Miller

Insider Reports History

Identity Who this page is about. 1 identity field
Location
Edmonton
SEC source record Original filing metadata and source links. 1 source field
Owner filing signature
/s/ Joseph M. Miller
Source evidence Original filing metadata and source links. 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joseph M. Miller

Form 4 holding Director

Avalo Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,239
Estimated value
Report date
31 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Joseph M. Miller

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .